PUBLISHER: The Business Research Company | PRODUCT CODE: 1947068
PUBLISHER: The Business Research Company | PRODUCT CODE: 1947068
Respiratory diagnostic devices and equipment are used to diagnose respiratory conditions like asthma, cystic fibrosis, and chronic obstructive pulmonary disease. These devices help measure lung function and oxygen levels, assisting healthcare providers in assessing and managing respiratory health.
The primary products within the respiratory devices and equipment (diagnostic) market encompass instruments and devices, as well as assays and reagents. These respiratory instruments and devices are critical for the diagnosis of various respiratory disorders. Diagnostic tests are available in various types, including traditional diagnostic tests, mechanical tests, imaging tests, and molecular diagnostic tests, all of which are employed in diagnosing conditions such as chronic obstructive pulmonary disease (COPD), lung cancer, asthma, tuberculosis, and other respiratory diseases. These diagnostic tools are used in a variety of healthcare settings, including hospital and clinical laboratories, physician offices, reference laboratories, and other end-user facilities.
Tariffs are influencing the respiratory devices and equipment (diagnostic) market by increasing costs of imported diagnostic instruments, reagents, imaging components, sensors, and electronic control units. Hospital laboratories and diagnostic centers in North America and Europe are most affected due to reliance on imported testing equipment, while Asia-Pacific faces increased production costs for diagnostic consumables. These tariffs are increasing test costs and slowing laboratory upgrades. However, they are also supporting domestic reagent manufacturing, regional device production, and localized development of respiratory diagnostic technologies.
The respiratory devices and equipment (diagnostic) market research report is one of a series of new reports from The Business Research Company that provides respiratory devices and equipment (diagnostic) market statistics, including respiratory devices and equipment (diagnostic) industry global market size, regional shares, competitors with a respiratory devices and equipment (diagnostic) market share, detailed respiratory devices and equipment (diagnostic) market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory devices and equipment (diagnostic) industry. This respiratory devices and equipment (diagnostic) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The respiratory devices and equipment (diagnostic) market size has grown strongly in recent years. It will grow from $8.36 billion in 2025 to $9.18 billion in 2026 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to increasing prevalence of respiratory disorders, expansion of pulmonary diagnostic laboratories, rising demand for early disease diagnosis, availability of advanced spirometry devices, growing use of oxygen monitoring tools.
The respiratory devices and equipment (diagnostic) market size is expected to see strong growth in the next few years. It will grow to $13.29 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to growing investments in respiratory disease diagnostics, increasing adoption of molecular and imaging-based tests, expansion of home-based diagnostic monitoring, rising focus on personalized respiratory care, continued innovation in diagnostic assay development. Major trends in the forecast period include increasing adoption of portable diagnostic respiratory devices, rising use of molecular diagnostic tests for respiratory diseases, growing integration of ai-based lung function analysis, expansion of point-of-care respiratory testing, enhanced focus on early disease detection.
The rising prevalence of various respiratory diseases is anticipated to drive the growth of the respiratory devices and equipment (diagnostic) market in the coming years. Respiratory diseases are medical conditions that affect the lungs and airways, disrupting normal breathing and oxygen exchange due to factors such as inflammation, infection, obstruction, or chronic structural damage. The increasing prevalence of respiratory diseases is attributed to the growing global burden of conditions that progressively reduce lung function and heighten susceptibility to long-term respiratory complications. Respiratory devices and equipment support the management of these diseases by improving airflow, enhancing oxygen delivery, and enabling more effective monitoring of lung function to help stabilize patient health. For example, in June 2025, according to the World Health Organization, a Switzerland-based organization, 81.7 million people are living with chronic respiratory diseases, and 6.8 million new cases are diagnosed each year. Therefore, the growing prevalence of respiratory diseases is contributing to the expansion of the respiratory devices and equipment (diagnostic) market.
Leading companies in the respiratory devices and equipment (diagnostic) market are focusing on developing advanced diagnostic technologies, such as automated nucleic acid purification instruments and the Applied Biosystems MagMAX Dx Viral/Pathogen NA Isolation Kit, to improve the accuracy and speed of viral detection. These instruments and kits enable the quick and reliable extraction of viral genetic material for precise diagnostic testing. For instance, in December 2023, Thermo Fisher Scientific Inc., a U.S.-based biotechnology company, introduced Sample Preparation Solutions for Respiratory Diagnostic Testing. The Thermo Scientific KingFisher Apex Dx automates the purification of up to 24 or 96 samples of DNA, RNA, proteins, or cells, ensuring high-quality results for respiratory tests. It integrates with the Applied Biosystems MagMAX Dx Viral/Pathogen NA Isolation Kit, providing a comprehensive solution for in vitro diagnostics. With advanced data management and cybersecurity features, this system supports smooth workflows from sample preparation to real-time PCR analysis, making it suitable for both research and diagnostic purposes.
In May 2025, ResMed Inc., a US-based leader in sleep, breathing, and home healthcare devices, acquired VirtuOx for an undisclosed amount. Through this acquisition, ResMed seeks to enhance its virtual care and in-home diagnostic capabilities by integrating VirtuOx's at-home testing services into its ecosystem, enabling earlier diagnosis and a more connected care pathway. VirtuOx is a US-based company that provides a virtual testing platform for sleep-disordered breathing and other respiratory conditions.
Major companies operating in the respiratory devices and equipment (diagnostic) market are ResMed Inc., Medtronic plc, Masimo Corporation, Fisher & Paykel Healthcare Limited, Koninklijke Philips N.V., Smiths Medical, GE Healthcare, Chart Industries Inc., Philips Healthcare, Becton Dickinson and Company (BD), Abbott Laboratories, Thermo Fisher Scientific Inc., Teleflex Incorporated, Invacare Corporation, Vyaire Medical Inc., Dragerwerk AG & Co. KGaA, Getinge AB, Drager Medical GmbH, bioMerieux, Bio-Rad Laboratories Inc - Bio-Rad Laboratories Inc., Cosmed S.r.l., Seegene Inc., SDI Diagnostics, GlaxoSmithKline plc, Hillrom, Hamilton Medical AG, Medline Industries Inc., 3M Company, Air Liquide, Allied Healthcare Products Inc., Armstrong Medical, Bio-Med Devices Inc., Breas Medical AB, CAIRE Inc., DeVilbiss Healthcare, Nihon Kohden Corporation, O2 Concepts LLC
Asia-Pacific was the largest region in the respiratory devices and equipment (diagnostic) market in 2025. North America was the second largest region in the respiratory devices and equipment (diagnostic) market. The regions covered in the respiratory devices and equipment (diagnostic) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the respiratory devices and equipment (diagnostic) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The respiratory devices and equipment (diagnostic) market consist of sales of spirometer, polysomnographs, and peak flow meters and monitoring devices are pulse oximeters, capnography, and gas analyzers that are used for diagnosis of respiratory diseases. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Respiratory Devices And Equipment (Diagnostic) Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses respiratory devices and equipment (diagnostic) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for respiratory devices and equipment (diagnostic) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The respiratory devices and equipment (diagnostic) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.